A Randomized Controlled Trial of Granulocyte Colony-Stimulating Factor for the Treatment of Severe Sepsis Due to Melioidosis in Thailand
Author(s) -
Allen C. Cheng,
Direk Limmathurotsakul,
Wirongrong Chierakul,
gluk Getchalarat,
Vanaporn Wuthiekanun,
Dianne Stephens,
Nick Day,
Nicholas J. White,
Wipada Chaowagul,
Bart J. Currie,
Sharon J. Peacock
Publication year - 2007
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/519261
Subject(s) - medicine , melioidosis , burkholderia pseudomallei , randomized controlled trial , granulocyte colony stimulating factor , sepsis , intensive care medicine , granulocyte , immunology , bacteria , chemotherapy , pathology , genetics , biology
Melioidosis is a tropical infectious disease associated with significant mortality. Most deaths occur early and are caused by fulminant sepsis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom